124 related articles for article (PubMed ID: 38353984)
1. Genetic and Clinical Correlates of AI-Based Brain Aging Patterns in Cognitively Unimpaired Individuals.
Skampardoni I; Nasrallah IM; Abdulkadir A; Wen J; Melhem R; Mamourian E; Erus G; Doshi J; Singh A; Yang Z; Cui Y; Hwang G; Ren Z; Pomponio R; Srinivasan D; Govindarajan ST; Parmpi P; Wittfeld K; Grabe HJ; Bülow R; Frenzel S; Tosun D; Bilgel M; An Y; Marcus DS; LaMontagne P; Heckbert SR; Austin TR; Launer LJ; Sotiras A; Espeland MA; Masters CL; Maruff P; Fripp J; Johnson SC; Morris JC; Albert MS; Bryan RN; Yaffe K; Völzke H; Ferrucci L; Benzinger TLS; Ezzati A; Shinohara RT; Fan Y; Resnick SM; Habes M; Wolk D; Shou H; Nikita K; Davatzikos C
JAMA Psychiatry; 2024 May; 81(5):456-467. PubMed ID: 38353984
[TBL] [Abstract][Full Text] [Related]
2. Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression.
Wen J; Fu CHY; Tosun D; Veturi Y; Yang Z; Abdulkadir A; Mamourian E; Srinivasan D; Skampardoni I; Singh A; Nawani H; Bao J; Erus G; Shou H; Habes M; Doshi J; Varol E; Mackin RS; Sotiras A; Fan Y; Saykin AJ; Sheline YI; Shen L; Ritchie MD; Wolk DA; Albert M; Resnick SM; Davatzikos C;
JAMA Psychiatry; 2022 May; 79(5):464-474. PubMed ID: 35262657
[TBL] [Abstract][Full Text] [Related]
3. Interactive Associations of Vascular Risk and β-Amyloid Burden With Cognitive Decline in Clinically Normal Elderly Individuals: Findings From the Harvard Aging Brain Study.
Rabin JS; Schultz AP; Hedden T; Viswanathan A; Marshall GA; Kilpatrick E; Klein H; Buckley RF; Yang HS; Properzi M; Rao V; Kirn DR; Papp KV; Rentz DM; Johnson KA; Sperling RA; Chhatwal JP
JAMA Neurol; 2018 Sep; 75(9):1124-1131. PubMed ID: 29799986
[TBL] [Abstract][Full Text] [Related]
4. Associations of Widowhood and β-Amyloid With Cognitive Decline in Cognitively Unimpaired Older Adults.
Biddle KD; Jacobs HIL; d'Oleire Uquillas F; Zide BS; Kirn DR; Properzi MR; Rentz DM; Johnson KA; Sperling RA; Donovan NJ
JAMA Netw Open; 2020 Feb; 3(2):e200121. PubMed ID: 32101313
[TBL] [Abstract][Full Text] [Related]
5. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
[TBL] [Abstract][Full Text] [Related]
6. Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia.
Nedelska Z; Schwarz CG; Lesnick TG; Boeve BF; Przybelski SA; Lowe VJ; Kremers WK; Gunter JL; Senjem ML; Graff-Radford J; Ferman TJ; Fields JA; Knopman DS; Petersen RC; Jack CR; Kantarci K
JAMA Netw Open; 2019 Dec; 2(12):e1916439. PubMed ID: 31790563
[TBL] [Abstract][Full Text] [Related]
7. Spatial Extent of Amyloid-β Levels and Associations With Tau-PET and Cognition.
Ozlen H; Pichet Binette A; Köbe T; Meyer PF; Gonneaud J; St-Onge F; Provost K; Soucy JP; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S;
JAMA Neurol; 2022 Oct; 79(10):1025-1035. PubMed ID: 35994280
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
9. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
10. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
11. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
[TBL] [Abstract][Full Text] [Related]
13. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities.
Tosto G; Zimmerman ME; Carmichael OT; Brickman AM;
JAMA Neurol; 2014 Jul; 71(7):872-7. PubMed ID: 24821476
[TBL] [Abstract][Full Text] [Related]
14. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.
Marchant NL; Reed BR; Sanossian N; Madison CM; Kriger S; Dhada R; Mack WJ; DeCarli C; Weiner MW; Mungas DM; Chui HC; Jagust WJ
JAMA Neurol; 2013 Apr; 70(4):488-95. PubMed ID: 23400560
[TBL] [Abstract][Full Text] [Related]
15. Genetic Moderation of the Association of β-Amyloid With Cognition and MRI Brain Structure in Alzheimer Disease.
Insel PS; Kumar A; Hansson O; Mattsson-Carlgren N;
Neurology; 2023 Jul; 101(1):e20-e29. PubMed ID: 37085326
[TBL] [Abstract][Full Text] [Related]
16. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease.
Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O
JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
18. Association of β-Amyloid and Vascular Risk on Longitudinal Patterns of Brain Atrophy.
Rabin JS; Pruzin J; Scott M; Yang HS; Hampton O; Hsieh S; Schultz AP; Buckley RF; Hedden T; Rentz D; Johnson KA; Sperling RA; Chhatwal JP
Neurology; 2022 Jul; 99(3):e270-e280. PubMed ID: 35473760
[TBL] [Abstract][Full Text] [Related]
19. Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
Grober E; Lipton RB; Sperling RA; Papp KV; Johnson KA; Rentz DM; Veroff AE; Aisen PS; Ezzati A
Neurology; 2022 Mar; 98(13):e1327-e1336. PubMed ID: 35197359
[TBL] [Abstract][Full Text] [Related]
20. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
